At Cardiomatics, we are committed to advancing cardiac research with AI-driven ECG analysis. We are proud to share our latest study, conducted with University Hospital Basel, and published in Diabetes Care. This marks our fourth collaboration, and we are eager to do more! The study explores how metformin can protect against the harmful effects of […]
Cardiovascular diseases, including arrhythmias, are a growing health concern in sub-Saharan Africa. Yet, access to advanced diagnostic tools like ambulatory rhythm monitoring remains scarce. A recent study in JACC: Clinical Electrophysiology highlights this issue and explores AI-powered solutions. The research team, including experts from UCSF, Weill Cornell Medicine, and Cardiomatics, examined arrhythmia prevalence and ways […]
When choosing a Holter software, it’s crucial to consider the specific needs of your practice. The right software can streamline your workflow, enhance diagnostic accuracy, and improve patient outcomes. Two key dimensions to consider from a product perspective are how the algorithm used for analysis was developed and how the software is deployed. Rule-based vs. […]
With more than 30,000 participants, the ESC Congress is by far the most important gathering for the cardiology community in Europe (and beyond). Actually, I do not recommend having any serious cardiac events between August 30th and September 2nd, as everyone will be in London at that time. Cardiomatics has been a part of the […]
Discover Italy’s innovative strides in telemedicine, which promises faster and more accessible cardiac care through a network of pharmacies. This pioneering approach marks a major shift of the patient pathway supported by AI-powered ECG technology.
Cardiomatics cooperates with the BIOTRONIK sales organisation in Germany to accelerate the growth of its leading AI-powered ECG analysis solution in the German market. BIOTRONIK Sales Organisation in Germany will distribute Cardiomatics’ AI-powered ECG analysis solution in combination with its net_ECG advanced ECG-Patch Holter Monitor. The partnership will drive the adoption of AI in early detection and management for individuals who may be at risk of a cardiac event.
Embark on a journey into the forefront of cardiac diagnostics with Cardiomatics, the cutting-edge AI-powered ECG interpretation solution. Experience swift insights into heart health, empowering healthcare professionals to intervene promptly. From sinus rhythm variations to critical arrhythmias, Cardiomatics provides a comprehensive overview of ECG events, ensuring accurate and consistent analysis. Embrace the efficiency of AI to streamline ECG interpretation, revolutionizing patient care outcomes. Uncover the intricacies of cardiac rhythm with Cardiomatics, shaping a future of tailored, proactive, and precise cardiac healthcare.
Maintaining high-quality ECG signals is crucial for accurate diagnosis and monitoring of heart conditions. Factors like electrode placement, patient movement, and external interference can impact signal quality, leading to misinterpretation and false results. Proper electrode placement, patient education, and advanced ECG analysis tools, including AI-powered solutions like Cardiomatics, are essential for improving signal quality and ensuring reliable diagnosis. Advanced technologies such as adaptive digital filters and AI algorithms further enhance signal quality by reducing noise and artifacts.
ECG patches and cable holter monitors are two main types of devices for long-term ECG monitoring. Patches, with their convenience and waterproof design, are dominating the market and experiencing rapid growth in usage. However, cable holters still offer specific features making them preferable for certain clinical scenarios. Find out more and discover key insights from our unique dataset comprising several hundreds of thousands of ECG recordings from a range of devices.
Refer a friend to Cardiomatics and they’ll enjoy a free month of Cardiomatics Pro while we donate to the World Heart Federation in your name. If they sign up for a minimum 12-month subscription, you both receive rewards. Join now to share the benefits of Cardiomatics and support heart health globally!
Introducing Cardiomatics v5: the world’s first AI-based ECG interpretation software certified under the Medical Device Regulation (MDR). With new features like AV block detection, fast-track analysis, and a revamped layout, Cardiomatics v5 empowers medical professionals with accurate and efficient ECG analysis. Join over 1,000 users and 200 clinics in experiencing streamlined workflow options and insightful reports. Request a free trial today to explore the potential of AI in ECG interpretation and enhance patient care.
Discover Cardiomatics’ latest feature: the ECG signal viewer. Now, access raw ECG signals directly within the Cardiomatics web panel, simplifying workflow for cardiologists. Responding to market demand, this enhancement offers efficiency and cost-effectiveness for medical professionals. Try it out with a free trial today.